VAS
WST icon

Vestmark Advisory Solutions’s West Pharmaceutical WST Stock Holding History

Vestmark Advisory Solutions’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.2M Buy
6,118
+4,266
+230% +$1.3M 0.02% 673
2026
Q1 		$464K Sell
1,852
-1,822
-50% -$453K 0.01% 1080
2025
Q4 		$1.01M Buy
3,674
+2,545
+225% +$696K 0.01% 791
2025
Q3 		$296K Sell
1,129
-134
-11% -$32.6K 0.01% 789
2025
Q2 		$276K Sell
1,263
-1,547
-55% -$331K ﹤0.01% 707
2025
Q1 		$629K Buy
2,810
+1,172
+72% +$323K 0.02% 485
2024
Q4 		$537K Buy
1,638
+214
+15% +$67.3K 0.02% 401
2024
Q3 		$427K Buy
1,424
+265
+23% +$81.2K 0.02% 399
2024
Q2 		$382K Sell
1,159
-104
-8% -$36.8K 0.02% 431
2024
Q1 		$500K Buy
1,263
+26
+2% +$9.62K 0.02% 385
2023
Q4 		$436K Buy
1,237
+417
+51% +$148K 0.02% 361
2023
Q3 		$308K Sell
820
-7,692
-90% -$2.97M 0.02% 342
2023
Q2 		$3.26M Buy
8,512
+1
+0% +$357 0.12% 213
2023
Q1 		$2.95M Buy
8,511
+1,972
+30% +$576K 0.13% 216
2022
Q4 		$1.54M Buy
6,539
+134
+2% +$31.8K 0.08% 320
2022
Q3 		$1.58M Buy
6,405
+424
+7% +$129K 0.09% 297
2022
Q2 		$1.81M Buy
5,981
+243
+4% +$79.1K 0.1% 258
2022
Q1 		$2.36M Buy
5,738
+694
+14% +$272K 0.13% 206
2021
Q4 		$2.37M Buy
5,044
+210
+4% +$90.4K 0.13% 192
2021
Q3 		$2.05M Buy
4,834
+537
+12% +$226K 0.14% 192
2021
Q2 		$1.54M Buy
4,297
+270
+7% +$89.2K 0.11% 234
2021
Q1 		$1.14M Buy
4,027
+1,074
+36% +$307K 0.1% 264
2020
Q4 		$837K Buy
2,953
+337
+13% +$94.6K 0.09% 268
2020
Q3 		$719K Buy
2,616
+208
+9% +$55K 0.1% 268
2020
Q2 		$547K Buy
2,408
+307
+15% +$60.3K 0.08% 284
2020
Q1 		$320K Buy
+2,101
New +$323K 0.06% 348
2019
Q4 		– Sell
-2,126
Closed -$302K – 526
2019
Q3 		$302K Sell
2,126
-12
-0.6% -$1.65K 0.05% 407
2019
Q2 		$268K Buy
2,138
+246
+13% +$29K 0.05% 435
2019
Q1 		$208K Buy
+1,892
New +$197K 0.04% 494

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Vestmark Advisory Solutions's WST Position: Q2 2026 in Review

Vestmark Advisory Solutions increased its West Pharmaceutical (WST) stake by 230% in Q2 2026, buying an estimated $1.3M and bringing the position to 6,118 shares worth $2.2M. The position accounts for 0.02% of the portfolio, ranked #673.

Vestmark Advisory Solutions first reported a position in WST in Q1 2019 and has held it in 29 quarters since. The position peaked at $3.26M in Q2 2023. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Vestmark Advisory Solutions held 6,118 shares of West Pharmaceutical worth $2.2M as of Q2 2026.
  • Vestmark Advisory Solutions bought 4,266 West Pharmaceutical shares in Q2 2026, an estimated $1.3M.
  • West Pharmaceutical made up 0.02% of Vestmark Advisory Solutions's portfolio in Q2 2026, its #673 holding.
  • Vestmark Advisory Solutions first reported a position in West Pharmaceutical in Q1 2019 and has held it in 29 quarters since.
  • Vestmark Advisory Solutions's West Pharmaceutical position peaked at $3.26M in Q2 2023.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Vestmark Advisory Solutions's 13F filing for Q2 2026, filed 14 Aug 2026.